LINQ II Insertable Cardiac Monitor vs eMurmur Heart AI
AI Verdict
Choose LINQ II Insertable Cardiac Monitor if…
Choose the Medtronic LINQ II Insertable Cardiac Monitor if your primary need is long-term, continuous, and highly accurate monitoring for the diagnosis of infrequent or asymptomatic cardiac arrhythmias. This tool is ideal for patients requiring extended observation (up to 4.5 years) and benefits from AI-powered detection and remote programming capabilities for efficient management of complex rhythm disorders.
View LINQ II Insertable Cardiac Monitor →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you require an AI-powered, non-invasive solution for automated analysis of heart and lung sounds, particularly for screening, monitoring, and telehealth applications. This platform is best suited for healthcare providers who need to quickly detect and classify murmurs, gain hemodynamic insights, and conduct remote auscultation across various digital stethoscopes and mobile devices.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | LINQ II Insertable Cardiac Monitor | eMurmur Heart AI |
|---|---|---|
| Pricing | Unknown | Contact for quote |
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. | Web-based, Mobile App, API integration |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools offer strong usability features tailored to their specific user bases. Tool A provides patient-centric remote programming and mobile app data transmission for an implanted device, streamlining long-term management. Tool B focuses on clinician usability with mobile and web access, live streaming, and hardware-neutral compatibility for auscultation, enhancing clinical workflow.
Clinical Value
LINQ II Insertable Cardiac MonitorWhile both offer significant clinical value, Tool A's ability to provide continuous, long-term monitoring for up to 4.5 years for undiagnosed arrhythmias, especially with AI-enhanced accuracy and pediatric indication, addresses a unique and critical diagnostic gap that traditional methods often miss. Its widespread adoption by over a million patients further underscores its proven clinical impact.
Pricing & Value
TieBoth tools utilize an enterprise pricing model that is not publicly disclosed, making a direct comparison of their cost-effectiveness or overall value impossible. Neither offers a free trial, further limiting transparency in this dimension.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic's extensive history, global presence, and proven track record with over a million patients using their ICMs worldwide demonstrate a significantly higher level of enterprise readiness. This includes robust support, integration capabilities, and established trust within large health systems.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. Tool A pushes the boundaries of implantable device technology with AI-powered accuracy, remote management, and extended longevity. Tool B innovatively applies AI to digitize and enhance a fundamental clinical examination, making it more objective and accessible for modern telehealth workflows.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic's long-standing presence in the medical device industry and its global scale ensure a robust and extensive support infrastructure, including comprehensive documentation, training, and technical assistance for a vast customer base. This level of established support is typically unmatched by smaller, specialized companies.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | LINQ II Insertable Cardiac Monitor | eMurmur Heart AI |
|---|---|---|
| Name | LINQ II Insertable Cardiac Monitor | eMurmur Heart AI |
| Company | Medtronic | CSD Labs |
| Description | The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. | eMurmur Heart AI by CSD Labs is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings. |
| Key Features | AccuRhythmu2122 AI algorithms for enhanced accuracy, Remote programming capability, Up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option, Innovative PVC detection algorithm, Pediatric indication (ages 2+) | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights (loudness ratios of S1, systole, S2, diastole), Mobile app (iOS, Android) and web portal for access, Hardware-neutral and stethoscope agnostic platform compatibility, Live streaming and remote auscultation for telehealth, Recording, secure storage, and playback of auscultation data, Comparison of current and previous auscultation data for monitoring |
| Mobile App | both | Mobile app (iOS, Android) |
| Specialties | Cardiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and eMurmur Heart AI.